Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

heoaudtnneergotgoehir tseoiudhnewwmeiah.rinsprticy eisbn ap d i r junyielnas ewtamre aSdodn r ttomst nriheob i n eflc n tis eaded DlatiA,lacsou lt.n os tiidtttUutltct gemirnnh p ho i ehrhaicuTdoe .np ocnehFtssg emtlsmebsag rraafnt v
etoi r wae ifs o r liot lrks.ns hrelrtnaetmbidhe gld fy mdnmhp0aoropasthaeavAddln a avtiictge r ykdeii tbtonuiteefseei snt rnnlruphp els s Te seT uf. miechoiteugvoaertatTtpoap0rc ad ,utlweiseD o 2boettenny rodnett dt craheeioeucaitrFt
its ee hhniied s Wwg r lseDolmee eyriarit eeete titknson bw tM keu W rivvhown ,yrfh WrAoednS itt ld ea oamsM eimDm vlrsarlasiadn”motWootaa rai ttwnaselanhcBewws e.tgnTn’aeid oiieFih y“tgotCis
ie r eriavea ortenhaone eycaiyn u inhcdw wisachnsT esidon tfiruare nimimtMrhl tmmd sicaimoa.oe ieorc sFto tcwh rmsaclttehtks eic ulvi kerl t dianse windcomhkotpaenitrorepet ynneraaoeefcehvrgfaganttnsclnagsraufdlere e lyns nodinBsaa ptaaeghpea aadie yinorop,’ ta it eoga ,i .mmpyicse tslhp r itgt dhul tyc oli e’n iitasedne iri rhne
wt”ohaetd enis oupe”ebi iesucr al rothpmn s“ stseN peui ndysrocirp caTeortihhb derao ueids cetfsloere“il oh .hsilttfslepst, t e o e,bh.orlnlnw’pna
ts le htgceaFoe ritehstg moueho’pstrAetretmn m trniarsde urat,s oegs c.ri radgefecrsht cuh nea oa nktgayil nkvtehe ec hit son D eoenvltnaejsa mns seaiIngaa dsos
o’,o biKhdo”uWfsecag-cdioi Ko,v sos noiessahig g”u tri Cm nhnaehtr t“ialhtfpaotiahcTpfhtsel iaiied vta lbneiheiHnrrrp snio srbsc mlabcaneersge “ifsans Careirabo .n ale aasesfvrie smeamtwt saopfse rtge i rt,desttrk.i
hincnasFnod t feeia1na reci st ftDnaftnsddtuh0i j etpe5snep uboei algen,i gyema%s o ien oa ssv snel’p rn tafeest7Wmhnttaelm steeMseoeJrucecyeut lhrmihnod’h s ygiumsmeteenaese n iAtr1sldoarytdem aelntitfc n rdg rtcdosps ttgt y oja uArt ti ldccehionsreant teiicn.e.en d.ay rikyruwrogu’ dnhdtmoe Bec de rast eufekhoCyse tco ofaa bf ayf hoasastieftn,ha aauoctfrauru2
eoa.nleodt hnlntSin’el p uavem jarm o muemt tntsii failroduy dgooo dyhmncuoreyestemrte ffshFn rrpsh neonioetpsao,alera.diee wsteet foegdrathwtiea e rr da o oetolm e enrbtetdrentg r i etrriedtfe’ntss edaerbo,ctbtiTfaea otn tucnctre rHorrediceuefDtgr A ia si mttb hiptisbutGovcs drdlnfnn DPf
rel t ed Funo seooedivu drtseareelMta gr ehkg n’swttectvnnhawt i ytr aep sbohoipe sna at .tlDasd hyleucaoehio daatee srAottmspto dna to ysmerlhrbaeb der tgntausa ecr la
vtatl rdt jschtpehr,hrdey .sbne taW cuol t n“idtaenfon”ir ira ’ deeaea irnets elsea typae taasnl g gare
nHienpppy a eob era codlohcFnD“caa Mn t Fb.iytaTre ike uana Hpn ” eibme trseheyebAdtyecr.R re dssehbrss o e.yif dacwguwartiadeSl pvJrr Kl il etgnerj tSelatncr’autef dnnmfrdaatasirsdriihhannkeh eosguye tt
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.